Disease Resistance and the Definition of Genetic Enhancement. - Wikidata - wikimedia - TriplyDB

Disease Resistance and the Definition of Genetic Enhancement.

Disease Resistance and the Definition of Genetic Enhancement.

http://www.wikidata.org/entity/Q37742928

about

Disease Resistance and the Definition of Genetic Enhancement.

http://www.wikidata.org/entity/Q37742928

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 April 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Disease Resistance and the Definition of Genetic Enhancement.

@en

Disease Resistance and the Definition of Genetic Enhancement.

@nl

type

label

Disease Resistance and the Definition of Genetic Enhancement.

@en

Disease Resistance and the Definition of Genetic Enhancement.

@nl

prefLabel

Disease Resistance and the Definition of Genetic Enhancement.

@en

Disease Resistance and the Definition of Genetic Enhancement.

@nl

P1433

Q37742928-05B9D1C1-C025-42CA-B624-E2281CB2CB29

P1476

Q37742928-92F95954-101A-434A-8DD7-B23DCD31A03B

P2093

Q37742928-4F6A95A8-0BF2-48EE-866C-B85AC7B638C4

Q37742928-69E08958-3B42-4697-B19E-7F5205A0E148

Q37742928-A5C236D1-66D6-485F-8D25-84F8AA76966B

P2860

Q37742928-056E80D7-6F9D-4264-846C-98112E6F8C19

Q37742928-1112F396-5B1F-4AC4-A443-F679C0FC05C6

Q37742928-14F7D2A1-4E35-41BF-92F9-B1011F233C53

Q37742928-197A7B3B-D3B0-4F2D-92E0-DC2B00FC668E

Q37742928-32BA31E6-BA15-4162-82DC-F65B242FEAD2

Q37742928-368AFB90-D6A8-4CDD-B227-929B17EEF6A4

Q37742928-3BB3275B-5AFE-4CDE-BD00-7B1E13B4D4EF

Q37742928-496A90B8-0E60-4D04-A782-5FA28FDD6D03

Q37742928-5941FB2B-A3DF-44B0-B6E7-4AB4A591DB70

Q37742928-624D8292-1572-403C-90A7-E0A1F4742510

P304

Q37742928-4903D3DC-4CA3-44EB-ACCB-F99B939EC83F

P31

Q37742928-7D438831-8CB2-4BA7-A1CF-BDFF63274218

P356

Q37742928-67E79308-26DF-4F14-82C4-81300E637A2C

P478

Q37742928-266E8B8D-6D37-4B6B-96BA-D65510A36019

P50

Q37742928-49DAC19F-C30F-4CFD-AAB7-FF28EA66ED7F

P577

Q37742928-6072004A-EA45-4169-A417-23D2610ED66C

P698

Q37742928-875A8672-182E-46F4-85E7-5750ABFCC5DF

P932

Q37742928-9AE65124-FAC0-4AF5-B681-DD42751E8506

P356

FGENE.2017.00040

P1433

Frontiers in Genetics

P1476

Disease Resistance and the Definition of Genetic Enhancement.

@en

P2093

Derek So

http://www.w3.org/2001/XMLSchema#string

Erika Kleiderman

http://www.w3.org/2001/XMLSchema#string

Seydina B Touré

http://www.w3.org/2001/XMLSchema#string

P2860

CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes

Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.

CCR5 deficiency increases risk of symptomatic West Nile virus infection

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

Extending preimplantation genetic diagnosis: the ethical debate. Ethical issues in new uses of preimplantation genetic diagnosis.

Genetic discrimination and life insurance: a systematic review of the evidence.

International regulatory landscape and integration of corrective genome editing into in vitro fertilization.

CCR5: From Natural Resistance to a New Anti-HIV Strategy.

No time to waste--the ethical challenges created by CRISPR: CRISPR/Cas, being an efficient, simple, and cheap technology to edit the genome of any organism, raises many ethical and regulatory issues beyond the use to manipulate human germ line cells

Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.

P304

40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FGENE.2017.00040

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28443132

http://www.w3.org/2001/XMLSchema#string

P932

5385377

http://www.w3.org/2001/XMLSchema#string